Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Moderna: Mrna-1469 Phase 1 Trial Conducted in Canada as Part of Expanded Collaboration with Coalition for Epidemic Preparedness Innovations

THOMSON REUTERS
·
Aug 04

Moderna: Under Cepi Agreement, Commits Minimum 500,000 Doses of Mrna-1469 Vaccine for Low- and Middle-Income Countries Under Access Pricing

THOMSON REUTERS
·
Aug 04

Moderna: Mrna-1469 Phase 1 Trial to Evaluate Safety & Immune Response for Bundibugyo Ebolavirus

THOMSON REUTERS
·
Aug 04

J.P. Morgan Remains a Sell on Moderna (MRNA)

TIPRANKS
·
Aug 04

Stock Track | Moderna Soars 5.53% Intraday on Analyst Upgrades and PDUFA Catalyst

Stock Track
·
Aug 04

Movement Alert|Moderna, Inc. Rises 5.28% in Regular Trading, Multiple Analyst Upgrades and PDUFA Date Catalyze Rally

Market Focus
·
Aug 04

Moderna is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

Moderna Facing Several Vaccine Headwinds in Near, Medium Term, RBC Says

MT Newswires Live
·
Aug 04

Movement Alert|Moderna, Inc. Rises 5.11% in Regular Trading, Multiple Institutions Raise Price Targets Ahead of Key PDUFA Date

Market Focus
·
Aug 03

Stock Track | Moderna Soars 5.16% Intraday as Analyst Price Target Hikes Boost Investor Confidence

Stock Track
·
Aug 03

UBS Raises Moderna Price Target to $50 From $45, Maintains Neutral Rating

MT Newswires Live
·
Aug 03

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Moderna (MRNA) and Stevanato Group (STVN)

TIPRANKS
·
Aug 03

Moderna : Bofa Global Research Raises Price Objective to $40 from $38

THOMSON REUTERS
·
Aug 03

Ocular Therapeutix Q2 Product Revenue Flat, Net Loss Widens on Higher Spending

Reuters
·
Aug 03

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Reuters
·
Aug 03

Krystal Biotech Q2 Revenue Rises on Vyjuvek Strength

Reuters
·
Aug 03

Israel's Compugen Q2 Revenue More than Doubles, Net Loss Narrows

Reuters
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

China's WuXi AppTec H1 Revenue Rises, Raises 2026 Guidance

Reuters
·
Aug 03

Does Moderna’s Wider 2026 Loss Amid Pipeline Spend Change The Bull Case For MRNA?

Simply Wall St.
·
Aug 03